AbbVie Splits from Abbott; Humira Is a Top Priority
By Marie Powers
Thursday, January 3, 2013
AbbVie Inc. launched Wednesday as an independent biopharma, splitting from Abbott in a plan initially disclosed in October 2011.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.